Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of MXN 3.19 trillion. The enterprise value is 4.00 trillion.

Market Cap	3.19T
Enterprise Value	4.00T

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Current Share Class	539.69M
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.17%
Owned by Institutions (%)	81.91%
Float	538.24M

Valuation Ratios

The trailing PE ratio is 22.99 and the forward PE ratio is 15.21.

PE Ratio	22.99
Forward PE	15.21
PS Ratio	4.82
PB Ratio	20.47
P/TBV Ratio	n/a
P/FCF Ratio	21.88
P/OCF Ratio	17.80
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.63, with an EV/FCF ratio of 27.40.

EV / Earnings	28.78
EV / Sales	6.26
EV / EBITDA	13.63
EV / EBIT	19.86
EV / FCF	27.40

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.40
Debt / EBITDA	3.29
Debt / FCF	6.84
Interest Coverage	3.66

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.12%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	7.93%
Return on Invested Capital (ROIC)	18.12%
Return on Capital Employed (ROCE)	17.78%
Weighted Average Cost of Capital (WACC)	6.35%
Revenue Per Employee	21.00M
Profits Per Employee	4.41M
Employee Count	31,500
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 22.77 billion in taxes.

Income Tax	22.77B
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +5.36% in the last 52 weeks. The beta is 0.47, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	+5.36%
50-Day Moving Average	5,793.65
200-Day Moving Average	5,298.23
Relative Strength Index (RSI)	50.97
Average Volume (20 Days)	909

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.69

Income Statement

In the last 12 months, Amgen had revenue of MXN 661.64 billion and earned 138.82 billion in profits. Earnings per share was 256.19.

Revenue	661.64B
Gross Profit	468.34B
Operating Income	208.37B
Pretax Income	161.60B
Net Income	138.82B
EBITDA	299.16B
EBIT	208.37B
Earnings Per Share (EPS)	256.19

Balance Sheet

The company has 164.35 billion in cash and 998.01 billion in debt, giving a net cash position of -833.66 billion.

Cash & Cash Equivalents	164.35B
Total Debt	998.01B
Net Cash	-833.66B
Net Cash Per Share	n/a
Equity (Book Value)	155.87B
Book Value Per Share	289.29
Working Capital	64.24B

Cash Flow

In the last 12 months, operating cash flow was 179.28 billion and capital expenditures -33.45 billion, giving a free cash flow of 145.83 billion.

Operating Cash Flow	179.28B
Capital Expenditures	-33.45B
Depreciation & Amortization	87.86B
Net Borrowing	-99.01B
Free Cash Flow	145.83B
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.

Gross Margin	70.78%
Operating Margin	31.49%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	45.22%
EBIT Margin	31.49%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 178.19, which amounts to a dividend yield of 2.90%.

Dividend Per Share	178.19
Dividend Yield	2.90%
Dividend Growth (YoY)	2.35%
Years of Dividend Growth	2
Payout Ratio	66.45%
Buyback Yield	-0.19%
Shareholder Yield	2.71%
Earnings Yield	4.35%
FCF Yield	4.57%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	7